Effect of tocilizumab in hospitalized patients with severe pneumonia COVID-19: a cohort study
Benjamin Rossi, View ORCID ProfileLee S. Nguyen, Philippe Zimmermann, Faiza Boucenna, Louis Dubret, Louise Baucher, Helene Guillot, Marie-Anne Bouldouyre, View ORCID ProfileYves Allenbach, Joe-Elie Salem, Paul Barsoum, Arezki Oufella, Helene Gros
doi: https://doi.org/10.1101/2020.06.06.20122341
Benjamin Rossi
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Lee S. Nguyen
2Research & innovation of CMC Ambroise Paré, 92200 Neuilly-sur-Seine, France
3Sorbonne Université, INSERM, Clinical Investigations Center Paris-Est, CIC-1901, AP.HP.6 Pitié-Salpétrière, 75013 Paris, France
Philippe Zimmermann
4Department of pharmacy, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Faiza Boucenna
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Louis Dubret
4Department of pharmacy, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Louise Baucher
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Helene Guillot
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Marie-Anne Bouldouyre
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Yves Allenbach
5Sorbonne Université, Department of Internal medicine and Clinical Immunology, AP.HP.6 Pitié-Salpétrière, 75013 Paris, France
Joe-Elie Salem
3Sorbonne Université, INSERM, Clinical Investigations Center Paris-Est, CIC-1901, AP.HP.6 Pitié-Salpétrière, 75013 Paris, France
Paul Barsoum
6Department of cardiology, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Arezki Oufella
4Department of pharmacy, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France
Helene Gros
1Department of Internal Medicine, Robert Ballanger hospital, 93600 Aulnay-sous-bois, France

Data Availability
data are not available
Posted June 09, 2020.
Effect of tocilizumab in hospitalized patients with severe pneumonia COVID-19: a cohort study
Benjamin Rossi, Lee S. Nguyen, Philippe Zimmermann, Faiza Boucenna, Louis Dubret, Louise Baucher, Helene Guillot, Marie-Anne Bouldouyre, Yves Allenbach, Joe-Elie Salem, Paul Barsoum, Arezki Oufella, Helene Gros
medRxiv 2020.06.06.20122341; doi: https://doi.org/10.1101/2020.06.06.20122341
Effect of tocilizumab in hospitalized patients with severe pneumonia COVID-19: a cohort study
Benjamin Rossi, Lee S. Nguyen, Philippe Zimmermann, Faiza Boucenna, Louis Dubret, Louise Baucher, Helene Guillot, Marie-Anne Bouldouyre, Yves Allenbach, Joe-Elie Salem, Paul Barsoum, Arezki Oufella, Helene Gros
medRxiv 2020.06.06.20122341; doi: https://doi.org/10.1101/2020.06.06.20122341
Subject Area
Subject Areas
- Addiction Medicine (280)
- Allergy and Immunology (580)
- Anesthesia (141)
- Cardiovascular Medicine (1965)
- Dermatology (187)
- Emergency Medicine (336)
- Epidemiology (11124)
- Gastroenterology (630)
- Genetic and Genomic Medicine (3202)
- Geriatric Medicine (310)
- Health Economics (567)
- Health Informatics (2051)
- Health Policy (864)
- Hematology (310)
- HIV/AIDS (686)
- Medical Education (319)
- Medical Ethics (92)
- Nephrology (339)
- Neurology (3004)
- Nursing (167)
- Nutrition (466)
- Oncology (1563)
- Ophthalmology (478)
- Orthopedics (186)
- Otolaryngology (266)
- Pain Medicine (203)
- Palliative Medicine (57)
- Pathology (403)
- Pediatrics (915)
- Primary Care Research (356)
- Public and Global Health (5616)
- Radiology and Imaging (1102)
- Respiratory Medicine (764)
- Rheumatology (342)
- Sports Medicine (290)
- Surgery (348)
- Toxicology (48)
- Transplantation (159)
- Urology (133)